Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹100 & Lump. ₹500

AUM (Fund size)

533 Cr

Lock In Period

N/A

Expense Ratio

2.37

Benchmark

BSE Healthcare Total Return

Exit Load

In respect of each purchase / switch-in of Units, an Exit Load of 1.00% is payable if Units are redeemed/ switched-out within 1 month from the date of allotment.No Exit Load is payable if Units are redeemed / switched-out after 1 month from the date of allotment.

Summary

Latest details for WhiteOak Capital Pharma and Healthcare Fund Growth include a 13.529 NAV as of Mar 13,2026 and returns since inception of --%. Minimum investments start at SIP ₹100. The WhiteOak Capital Pharma and Healthcare Fund Growth AUM is ₹533 Cr, with a lock-in of N/A years, expense ratio of 2.37%, and benchmark BSE Healthcare Total Return. Exit load is - In respect of each purchase / switch-in of Units, an Exit Load of 1.00% is payable if Units are redeemed/ switched-out within 1 month from the date of allotment.No Exit Load is payable if Units are redeemed / switched-out after 1 month from the date of allotment.. In the growth review for 1M Month/Year, the fund recorded 0.62% returns, against a category average of -2.20% and a category best of 14.70%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M0.62-2.2014.70
6M-1.850.6647.64
1Y14.135.01124.59
3Y0.0011.89234.84

Portfolio Analysis

  • Equity: 95.29%
  • Debt: 4.71%
  • Others
As on: 2026-01-31
View allocation % by

1. Sun Pharmaceutical Industries Limited10.72%
2. JB Chemicals & Pharmaceuticals Limited9.11%
3. Divi's Laboratories Limited5.48%
4. Lupin Limited5.16%
5. Laurus Labs Limited4.41%
6. Alkem Laboratories Limited3.36%
7. Ajanta Pharma Limited2.56%
8. Neuland Laboratories Limited2.25%
9. Sai Life Sciences Limited2.05%
10. Corona Remedies Limited2.03%
11. Acutaas Chemicals Limited1.97%
12. Abbott India Limited1.78%
13. Emcure Pharmaceuticals Limited1.55%
14. AstraZeneca Pharma India Limited1.55%
15. Pfizer Limited1.49%
16. Eris Lifesciences Limited1.36%
17. Strides Pharma Science Limited1.31%
18. Aarti Pharmalabs Limited1.02%
19. Sudeep Pharma Limited0.98%
20. Supriya Lifescience Limited0.94%
21. Zota Health Care Limited0.87%
22. Cipla Limited0.80%
23. IPCA Laboratories Limited0.78%
24. Shilpa Medicare Limited0.49%
25. Anthem Biosciences Limited0.42%
26. Orchid Pharma Limited0.32%
27. Mankind Pharma Limited0.24%

1. Fortis Healthcare Limited5.33%
2. Apollo Hospitals Enterprise Limited4.90%
3. Max Healthcare Institute Limited4.52%
4. Krishna Institute Of Medical Sciences Limited2.71%
5. Narayana Hrudayalaya Limited1.93%
6. Vijaya Diagnostic Centre Limited1.68%
7. Kovai Medical Center and Hospital Limited1.35%
8. Thyrocare Technologies Limited1.03%
9. Jupiter Life Line Hospitals Limited0.82%
10. Dr.Agarwals Eye Hospital Limited0.59%

1. Shaily Engineering Plastics Limited1.90%

1. Navin Fluorine International Limited1.70%

1. Aether Industries Limited1.23%

About Fund

WhiteOak Capital Pharma and Healthcare Fund Growth managed by WhiteOak Capital Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹533 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.37. Under the expert guidance of Ramesh Mantri ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Peer Comparison

Fund Name1Y3Y
This FundEdelweiss Financial Services Fund Growth00
This FundMotilal Oswal Consumption Fund Growth00
This FundWhiteOak Capital Pharma and Healthcare Fund Growth14.13010
This FundICICI Prudential PSU Equity Fund Growth20.7485107.3724
This FundNippon India Taiwan Equity Fund Growth121.493221.1804

FAQs

WhiteOak Capital Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of WhiteOak Capital Pharma and Healthcare Fund Growth is 2.37. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

WhiteOak Capital Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 0.62%
  • 6 Months : -1.85%
  • 1 Year : 14.13%
  • 3 Years : 0.00%
Returns of WhiteOak Capital Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ 13.529 as on Mar 13,2026. Since inception, the return has been 0.00%.

You can invest in WhiteOak Capital Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of WhiteOak Capital Pharma and Healthcare Fund Growth is ₹533 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in WhiteOak Capital Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500